Concepedia

Publication | Open Access

Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial

DOIFull Paper Access

145

Citations

42

References

2019

Year

Herman Depypere, D. Timmerman, Gilbert Donders, Peter Sieprath, Steven Ramael, Jean Combalbert, Hamid R. Hoveyda, Graeme L. Fraser
The Journal of Clinical Endocrinology & Metabolism

Abstract

Fezolinetant rapidly and significantly reduced moderate/severe VMSs, supporting its potential as an effective nonhormonal treatment option for menopausal women.

References

YearCitations

Page 1